B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125
B of A Securities analyst Joanna Gajuk downgrades Addus HomeCare (NASDAQ:ADUS) from Buy to Neutral and lowers the price target from $140 to $125.
Share
Why It Matters
A big bank analyst changed her mind about Addus HomeCare. She now thinks the stock is fairly priced, not a good buy.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.